Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
01/2014
01/22/2014CN103520158A Contains pioglitazone oral formulation
01/22/2014CN103520121A Vecuronium bromide freeze-dried powder injection for injection and preparation method thereof
01/22/2014CN103520117A Baclofen microballoon preparation and preparation method thereof
01/16/2014CA2876512A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
01/16/2014CA2876499A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
01/15/2014EP2683733A1 Tfeb variants and uses thereof
01/15/2014EP2683444A1 Tfeb phosphorylation inhibitors and uses thereof
01/15/2014EP2683404A1 The method of treating amyotrophic lateral sclerosis
01/15/2014CN103508953A Salts of nuciferine derivatives
01/15/2014CN103508952A Salts of N-nornuciferine derivatives
01/15/2014CN103508951A Salts of 2-hydroxy-1-methoxyaporphine derivative
01/15/2014CN103505743A Cell micro-particles containing functional microRNA/siRNA and application thereof
01/15/2014CN103505721A Method of treating myasthenia gravis
01/15/2014CN103505713A Traditional Chinese medicine formula for treating disharmony between ying and wei syndrome muscle numbness disease
01/15/2014CN103505524A Medicine for treating lumbar muscle strain and preparation method thereof
01/15/2014CN103006815B Traditional Chinese medicine external use film agent for treating pain diseases caused by rheumatoid bone diseases, cervical muscle and lumbar muscle degeneration, and scapulohumeral periarthritis
01/15/2014CN102441060B Traditional Chinese medicine preparation for treating progressive muscular atrophy symptom
01/15/2014CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase
01/14/2014CA2342243C Stable liquid formulations of botulinum toxin
01/09/2014WO2013173506A3 Kinase inhibitors for use in the treatment of muscular degradation
01/09/2014US20140010798 Albumin fusion proteins
01/09/2014CA2877644A1 Oligonucleotide for the treatment of muscular dystrophy patients
01/08/2014CN103501793A Antisense oligonucleotides
01/08/2014CN103495003A Traditional Chinese medicine composition for treating tetanus
01/08/2014CN103494842A Preparation method of drug for treating acute lumbar sprain
01/08/2014CN103494795A Peptide compounds used for treating diseases associated with hyperexcitability disorders and dysfunction of an ion channel
01/08/2014CN103007024B Traditional Chinese medicine composition for treating prosopospasm
01/08/2014CN102940761B Traditional Chinese medicine for treating graphospasm
01/08/2014CN102781436B Methods for treating fibromyalgia syndrome
01/08/2014CN102731616B Tetanus-toxin-neutralizing B cell epitope peptide and application thereof
01/08/2014CN102382102B Amide compound
01/07/2014US8624019 ENA nucleic acid drugs modifying splicing in mRNA precursor
01/07/2014US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues
01/07/2014CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
01/03/2014WO2014004647A1 A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
01/03/2014WO2014004470A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
01/03/2014WO2014003154A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function
01/03/2014WO2014001314A1 Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
01/03/2014WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof
01/03/2014CA2877953A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function
01/03/2014CA2877923A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof
01/03/2014CA2877874A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
01/03/2014CA2877861A1 A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
01/02/2014US20140004095 Albumin fusion proteins
01/01/2014EP2679237A1 Myostatin inhibition for enhancing muscle and/or improving muscle function
01/01/2014EP2678017A2 Asymmetric ureas and medical uses thereof
01/01/2014CN103479654A Boron-containing small molecules as anti-inflammatory agents
12/2013
12/31/2013US8617598 Pharmaceutical compositions comprising colloidal silicon dioxide
12/31/2013US8617539 Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction
12/27/2013WO2013189241A1 Pyrimidine diamine derivative, preparation method therefor, and pharmaceutical uses thereof
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/25/2013EP2675771A1 4-hydroxybutyric acid deuterated analogs
12/25/2013CN103476791A Novel WNT compositions and therapeutic uses of such compositions
12/25/2013CN103476423A Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
12/25/2013CN103476422A Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
12/25/2013CN103468504A Pilose antler healthcare wine
12/25/2013CN103463688A Bamboo medicine jar and transparent vacuum jar combination technique
12/25/2013CN103463610A Traditional Chinese medicine for treating disharmony between ying and wei type muscle impediment disease
12/25/2013CN103463349A Traditional Chinese medicine composition for treating acute lumbar sprain
12/25/2013CN103462885A Stable rocuronium injection preparation and preparation method thereof
12/24/2013CA2587188C Pharmaceutical preparation for the treatment of friedreich's ataxia
12/19/2013WO2013187727A1 Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
12/19/2013US20130338186 Amides of acetic and propionic acids
12/19/2013CA2877669A1 Dual receptor antagonistic antigen-binding proteins and uses thereof
12/19/2013CA2874988A1 Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
12/18/2013EP2673289A1 Viral vectors with modified transduction profiles and methods of making and using the same
12/18/2013EP2672977A1 Antisense oligonucleotides
12/18/2013CN103459590A Pluripotent stem cell capable of being isolated from fat tissue or umbilical cord of biological body
12/18/2013CN103459369A 胍化合物 Guanidine compound
12/18/2013CN103458970A Tfeb phosphorylation inhibitors and uses thereof
12/18/2013CN103458891A Nutritional composition
12/18/2013CN103450359A Antagonist antibodies against GDF-8 and uses in treatment ofals and other GDF-8-associated disorders
12/18/2013CN103450312A New crystal form of vecuronium bromide, and preparation method and use thereof
12/18/2013CN103450311A New crystal form of vecuronium bromide, and preparation method and use thereof
12/18/2013CN103446556A Traditional Chinese medicine for treating scapulohumeral periarthritis
12/18/2013CN103446509A Traditional Chinese medicine for treating soft tissue injury
12/18/2013CN103446460A Chinese herba preparation for nursing polio sequela and preparation method thereof
12/18/2013CN103446407A Pure traditional Chinese medicine preparation for treating cervical spondylosis and lumbar spondylosis and fumigant of pure traditional Chinese medicine preparation
12/18/2013CN103446291A Traditional Chinese medicine composition for treating soft tissue injury
12/18/2013CN102824553B Tincture for removing arthralgia and myalgia
12/18/2013CN102631368B Application of bone marrow mesenchymal stem cells (MSCs) to preparation of drugs for treating autoimmune diseases
12/18/2013CN102088978B Ameliorating or therapeutic agent for dyslipidemia
12/18/2013CN101857554B Cinamic compounds and derivatives therefrom for inhibition of histone deacetylase
12/18/2013CN101448527B Cell-matrix microspheres, methods for preparation and applications
12/17/2013CA2754154C Method for the industrial purification of biologically active phycotoxins
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/17/2013CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/12/2013WO2013183747A1 Agent for converting skeleton muscle into slow-fiber-type one
12/12/2013US20130331354 Method and composition utilizing larch wood extracts in animal feed
12/12/2013US20130331310 Prodrug of an Ice Inhibitor
12/12/2013US20130330332 Treatment of pemphigus
12/11/2013CN103442595A Functional foods comprising diamine oxidase and uses thereof
12/11/2013CN103432681A Medicine preparation and device comprising NRG (neuregulin)
12/11/2013CN103432426A Traditional Chinese medicinal tablets for treating neuralgic amyotrophy and preparation method thereof
12/11/2013CN103432425A Medicinal preparation for treating tetanus of animals
12/11/2013CN103432369A Medicament for treating narcotic adverse reactions
12/11/2013CN103432200A Medicament for treating cardiovascular and orthopedic diseases
12/11/2013CN103432132A Pridinol mesylate diclofenac sodium injection and preparation method thereof
12/11/2013CN103432118A Application of andrographolide derivatives in preparing medicaments for preventing and treating neurodegenerative diseases
12/11/2013CN103432093A Pridinol methanesulfonate matrix sustained-release tablet and preparation method thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 233